The purpose of this registry is to evaluate the outcome of pregnancy in women exposed to
VIBATIV at any time during pregnancy. There are no mandated physician visits for the
registry.
Details
Lead Sponsor:
Cumberland Pharmaceuticals Theravance Biopharma Antibiotics, Inc.